167 related articles for article (PubMed ID: 9818464)
41. Achievement of complete molecular responses in late chronic phase chronic myeloid leukaemia patients treated with pulsed imatinib while in minimal residual disease.
Breccia M; Cannella L; Stefanizzi C; Santopietro M; De Cuia R; Diverio D; Alimena G
Leuk Res; 2009 May; 33(5):645-8. PubMed ID: 19062090
[TBL] [Abstract][Full Text] [Related]
42. Approval summary: imatinib mesylate capsules for treatment of adult patients with newly diagnosed philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase.
Johnson JR; Bross P; Cohen M; Rothmann M; Chen G; Zajicek A; Gobburu J; Rahman A; Staten A; Pazdur R
Clin Cancer Res; 2003 Jun; 9(6):1972-9. PubMed ID: 12796358
[TBL] [Abstract][Full Text] [Related]
43. [Cytogenetic analysis and bcr/abl mRNA detection in chronic myeloid leukemia].
Yao B; Guo M; Pian H
Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):137-9. PubMed ID: 11601240
[TBL] [Abstract][Full Text] [Related]
44. [STI 571 for treating 19 patients with chronic-phase chronic myeloid leukemia].
Meng FY; Zheng WY; Liu XL; Xu B; Song LL; Zhang Y; Huang F
Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1149-50. PubMed ID: 14625174
[TBL] [Abstract][Full Text] [Related]
45. [Results of imatinib therapy in late-stage chronic myeloid leukemia after treatment with interferon-alpha].
Molnár L; Nagy A; Dávid M; Szomor A; Méhes G; Kovács G; Losonczy H
Orv Hetil; 2004 Apr; 145(17):901-7. PubMed ID: 15170967
[TBL] [Abstract][Full Text] [Related]
46. [Interferon alpha in the treatment of chronic myeloid leukemia].
Tóthová E; Fricová M; Stecová N; Svorcová E; Surová M; Kafková A; Guman T; Mudronová B
Vnitr Lek; 1996 May; 42(5):327-30. PubMed ID: 8768291
[TBL] [Abstract][Full Text] [Related]
47. Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon alpha.
Berger U; Engelich G; Maywald O; Pfirrmann M; Hochhaus A; Reiter A; Metzgeroth G; Gnad U; Hasford J; Heinze B; Heimpel H; Hossfeld DK; Kolb HJ; Löffler H; Pralle H; Queisser W; Hehlmann R;
Leukemia; 2003 Sep; 17(9):1820-6. PubMed ID: 12970782
[TBL] [Abstract][Full Text] [Related]
48. [Interferon-alpha therapy in chronic myeloid leukemia].
Lutz D
Wien Med Wochenschr; 1993; 143(16-17):416-9. PubMed ID: 8273364
[TBL] [Abstract][Full Text] [Related]
49. [Value of interferon-alpha in treatment of chronic myeloid leukemia].
Thaler J
Acta Med Austriaca; 1993; 20(3):65-9. PubMed ID: 8368048
[TBL] [Abstract][Full Text] [Related]
50. [Busulfan versus busulfan-interferon as maintenance therapy in chronic myeloid leukemia].
López Hernández MA; Flores-Chapa JD; Trueba Christy E; Borbolla Escoboza JR; Carrillo Rosales T
Rev Invest Clin; 1996; 48(4):281-7. PubMed ID: 8966391
[TBL] [Abstract][Full Text] [Related]
51. Interferon therapy, but not busulfan restores normal-sized megakaryopoiesis in CML--a comparative histo- and immunomorphometric study.
Thiele J; Zirbes T; Kvasnicka HM; Niederle N; Dammasch J; Schmidt M; Windecker R; Leder LD; Diehl V; Fischer R
Anal Cell Pathol; 1996 Jun; 11(1):31-42. PubMed ID: 8844103
[TBL] [Abstract][Full Text] [Related]
52. A prospective comparison of alpha-IFN and conventional chemotherapy in Ph+ chronic myeloid leukemia. Clinical and cytogenetic results at 2 years in 322 patients. The Italian Cooperative Study Group on Chronic Myeloid Leukemia.
Haematologica; 1992; 77(3):204-14. PubMed ID: 1427426
[TBL] [Abstract][Full Text] [Related]
53. The role of interferon in the treatment of chronic myelogenous leukemia in chronic phase.
Guilhot F
Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S39-46. PubMed ID: 8177714
[TBL] [Abstract][Full Text] [Related]
54. Use of interferon in the treatment of chronic myelogenous leukemia.
Talpaz M
Semin Oncol; 1994 Dec; 21(6 Suppl 14):3-7. PubMed ID: 7992097
[TBL] [Abstract][Full Text] [Related]
55. [Chronic myelogenous leukemia with long-term hypoplasia induced by alpha-interferon and hydroxyurea].
Motomura S; Sakai R; Tomita N; Fujimaki K; Hattori M; Fujisawa S; Mohri H; Takahashi N; Maruta A; Kodama F; Okubo T
Rinsho Ketsueki; 1998 Apr; 39(4):302-7. PubMed ID: 9597898
[TBL] [Abstract][Full Text] [Related]
56. [Recent progress in therapy for chronic myelogenous leukemia].
Urabe A
Gan To Kagaku Ryoho; 1997 Jul; 24(9):1066-73. PubMed ID: 9239158
[TBL] [Abstract][Full Text] [Related]
57. Effects of interferon-alpha therapy on lymphocyte subpopulations in patients with chronic myeloid leukemia.
Sacchi S; Cortes J; Kantarjian H; Talpaz M
Hematopathol Mol Hematol; 1997-1998; 11(1):41-7. PubMed ID: 9439979
[TBL] [Abstract][Full Text] [Related]
58. Clinical experience of antibodies to interferon-alpha during treatment of chronic myeloid leukemia.
Russo D; Candoni A; Grattoni R
J Interferon Cytokine Res; 1997 Jul; 17 Suppl 1():S47-9. PubMed ID: 9241616
[TBL] [Abstract][Full Text] [Related]
59. Randomized study of the combination of hydroxyurea and interferon alpha versus hydroxyurea monotherapy during the chronic phase of chronic myelogenous leukemia (CML Study II). The German CML Study Group.
Hehlmann R; Heimpel H; Hossfeld DK; Hasford J; Kolb HJ; Löffler H; Pralle H; Queisser W; Hochhaus A; Tichelli A; Fett W; Schmitz N; Reiter A; Griesshammer M; Pfeifer W; Bümler M; Kamp T; Tobler A; Eimermacher H; Kuse R; Berger U; Ansari H
Bone Marrow Transplant; 1996 May; 17 Suppl 3():S21-4. PubMed ID: 8769695
[TBL] [Abstract][Full Text] [Related]
60. [Concordant improvement of progressive systemic sclerosis and chronic myelogenous leukemia with interferon-alpha treatment].
Watanabe S; Sugihara T; Takahashi M; Ata K; Kanzaki A; Yamada O; Yawata Y
Rinsho Ketsueki; 1994 Sep; 35(9):895-7. PubMed ID: 7967060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]